Nucleus® Hybrid L24 Cochlear Implant System
FDA premarket approval P130016/S047 · decided 2022-03-03
Approval details
- PMA number
- P130016
- Supplement
- S047
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Nucleus® Hybrid L24 Cochlear Implant System
- Generic name
- Cochlear implant with combined electrical stimulation and acoustic amplification
- Applicant
- Cochlear Americas
- Date received
- 2022-02-01
- Decision date
- 2022-03-03
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- PGQ
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Lone Tree, CO
- Statement
- Introduction of an alternate laser welding system to the current system, to perform hermitization hole welding in the implant assembly.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.